${headerCss}

National Lung Cancer Roundtable
Lung Cancer Screening Webinar Series

date_range
June 30–Nov. 17
timer
noon–1pm ET
credit_card
Free
To narrow the knowledge gaps regarding the new lung cancer screening eligibility criteria from the U.S. Preventive Services Task Force, the American Cancer Society National Lung Cancer Roundtable, in partnership with the ACR®, American Academy of Family Physicians, American Thoracic Society, and American College of Chest Physicians, will host a monthly webinar series from June 30–November 17.

The webinar series, sponsored by AstraZeneca and Genentech, a member of the Roche Group, will feature perspectives from key stakeholder groups, including patients, primary care physicians, pulmonologists, radiologists, epidemiologists, behavioral scientists, oncologists and thoracic surgeons. 

See below for the dates, topic and agenda for each webinar.

Register Today

June 30 ǀ On-Demand
Review of Expanded USPSTF Lung Cancer Screening Recommendations
• Why Were the USPSTF Recommendations Expanded? Who is Now Eligible?
• What Do the New Criteria Mean for:
○ Disparities/health equity
○ Risk assessment
○ Uptake/adherence
○ Policy/reimbursement
• Overview of First Million Screens in ACR Lung Cancer Screening Registry
• Advocate Perspective

July 28 ǀ On-Demand
Lessons Learned from a Lung Cancer Screening Program: Shared Decision Making, Smoking Cessation & Adherence
• Impact of COVID-19 on Lung Cancer Screening
• Conducting Quality SDM and Tobacco Cessation Counseling (CMS requirements, use of decision aids, etc.)
• How to Track and Increase Adherence to Follow-up Screening

Aug. 25 ǀ On-Demand
Role of the Primary Care Provider and Nurse Navigator in Lung Cancer Screening
• Lung Cancer Screening as a Vehicle to Save Lives and Advance Better Health for Eligible Individuals
• Assessing Eligibility for Screening
• Conducting Quality SDM and Tobacco Cessation Counseling in Brief Clinical Encounters: Best Practices
• Updated AAFP Recommendations
• Lung Cancer and the Primary Care Provider CME (LuCa)

Sept. 29 ǀ Noon-1pm ET
Meeting Patients Where They Are: Lung Cancer Screening Outreach Efforts Among Vulnerable Populations (Part 1)
• Advocate Perspective: How Lack of Access Impacts All Patients and Exacerbates Disparities
• Lung Cancer Screening in Low-income Populations in Chicago
• Mobile Lung Cancer Screening in North Carolina
• ACS Return to Screening Campaign
Speaker: Efren Flores, MD
Panelists: Andrea Borondy Kitts, MS, MPH; Kelly Irwin, MD, MPH; Dorothy Rhoades, MD, MPH; Mellisa Wheeler, BSW, MHA

Oct. 6 ǀ Noon-1pm ET
Meeting Patients Where They Are: Tools for Building Capacity (Part 2)
• Advocate Perspective
• NLCRT Lung Cancer Coalition-Building Guide
• NLCRT Early Detection Modeling Tool
Speaker: Christopher Lathan, MD, MS, MPH
Panelists: Debra Dyer, MD, FACR; Timothy Mullett, MD, MBA; Carey Thomson, MD, MPH

Nov. 3 ǀ Noon-1pm ET
Lung Cancer in Women (This webinar is offered to women who smoke and meet USPSTF criteria)
• Increasing Awareness About the Availability of LCS and Who Is Eligible by Partnering with OB-GYN Societies Who Can Promote
• Leveraging Mammography to Enroll Eligible Women for Lung Cancer Screening
Speaker: M. Patricia Rivera, MD, ATSF, FCCP
Panelists: Leah Backhus, MD, MPH; Narjust Duma, MD; Kim Sandler, MD

Nov. 17 ǀ Noon-1pm ET
Advances in Lung Cancer Treatment and Care: Long-Term Survivorship Is Now a Reality
• NLCRT Biomarker ECHO Clinic Pilot to Increase Clinician Awareness and Knowledge of Biomarker Testing
Speaker: Raymond Osarogiagbon, MBBS
Panelists: Jill Feldman, Bruce Johnson, MD; Elyse Park, PhD, MPH; Anurag Singh, MD; Brendon Stiles, MD